Concepedia

Publication | Open Access

Once‐weekly semaglutide use in patients with type 2 diabetes: Real‐world data from the <scp>SURE</scp> Italy observational study

DOIFull Paper Access

27

Citations

27

References

2023

Year

Raffaele Napoli, Cesare Berra, Andrei‐Mircea Catarig, Chiara Di Loreto, Emily Donatiello, Tina Landsvig Berentzen, Dario Pitocco, Francesco Giorgino
Diabetes Obesity and Metabolism

Abstract

In routine clinical practice in Italy, patients with T2D treated with once-weekly semaglutide for 30 weeks achieved clinically significant improvements in HbA1c, body weight and other outcomes.

References

YearCitations

Page 1